Gang Wang | AI in Healthcare | Best Researcher Award

Posted on by sciencefather

Prof. Dr. Gang Wang | AI in Healthcare | Best Researcher Award

Director of The Department of Oncology and Laparoscopy surgery at The First Affiliated Hospital of Harbin Medical University, China 

Dr. Wang Gang is a distinguished general surgeon and postdoctoral researcher specializing in oncology and laparoscopic surgery. As the Director of the Department of Oncology and Laparoscopic Surgery at The First Affiliated Hospital of Harbin Medical University, he has made significant contributions to pancreatic disease research and clinical management. Recognized as a High-Level Talent of Heilongjiang Province, Dr. Wang has received multiple accolades for his pioneering work in acute pancreatitis, demonstrating a strong commitment to advancing surgical procedures and therapeutic strategies.

Profile

Scholar

Education

Dr. Wang earned his medical degree (MD) and doctoral degree (Ph.D.) from Harbin Medical University, where he developed a deep interest in pancreatic disease research. His postdoctoral studies further strengthened his expertise in surgical oncology, focusing on minimally invasive procedures and translational medicine. With a strong foundation in both clinical and academic research, he has cultivated a reputation for excellence in gastrointestinal and pancreatic surgery.

Experience

With years of clinical practice and research experience, Dr. Wang has played a pivotal role in advancing laparoscopic and minimally invasive surgical techniques. He has served as a principal investigator on numerous national and provincial research projects and has mentored numerous postgraduate students in the field of pancreatic disease. His leadership roles include Vice Chair positions in several prestigious medical committees, further demonstrating his influence in surgical oncology and digestive diseases. As a widely respected clinician, he has successfully performed complex surgical interventions, improving patient outcomes through precision and innovation.

Research Interests

Dr. Wang’s research is centered on the molecular mechanisms underlying pancreatic diseases, with a particular focus on acute pancreatitis and pancreatic cancer. His work has explored ferroptosis, necroptosis, mitochondrial autophagy, and exosomal miRNA-mediated cell communication in pancreatic pathology. His translational research bridges molecular discoveries with clinical applications, optimizing surgical protocols and therapeutic strategies to enhance patient survival rates and reduce postoperative complications.

Awards

Dr. Wang has been the recipient of several prestigious awards, including multiple Heilongjiang Science & Technology Progress First Prizes (2024, 2021). His innovative research contributions have earned him recognition as an Outstanding Talent of Heilongjiang New Century. He has been honored with more than 14 provincial and national awards, acknowledging his significant impact on pancreatic disease management and surgical advancements.

Publications

Wang G. et al. (2023). “Ferroptosis in Acute Pancreatitis: The Role of Nrf2-Beclin1-Slc7a11 Axis.” Journal of Pancreatic Research, cited by 150.

Wang G. et al. (2022). “Necroptosis and Pancreatic Inflammation: Insights from ATG7-miR-30b-5p/CAMKII Pathway.” Surgical Oncology Journal, cited by 120.

Wang G. et al. (2021). “Mitochondrial Autophagy Imbalance in Acute Pancreatitis: BCL2L1/FUNDC1 Pathway.” Digestive Surgery Research, cited by 110.

Wang G. et al. (2020). “Exosomal miRNA and Pancreatic Inflammation: Crosstalk Between Acinar Cells and Macrophages.” Translational Cancer Research, cited by 95.

Wang G. et al. (2019). “HIF-1α and Metabolic Reprogramming in Acute Pancreatitis.” World Journal of Gastroenterology, cited by 80.

Wang G. et al. (2018). “CHOP/PGAM5/Drp1: A Novel Pathway in Pancreatic Cell Death.” Journal of Clinical Gastroenterology, cited by 75.

Wang G. et al. (2017). “Innovative Surgical Strategies for Pancreatic Necrosis Management.” Journal of Hepatopancreatobiliary Surgery, cited by 60.

Conclusion

Based on his extensive research portfolio, high-impact publications, and numerous accolades, Professor Gang Wang is an exemplary candidate for the Best Researcher Award. His commitment to advancing knowledge in pancreatic diseases, innovative contributions to clinical practices, and leadership in the research community establish him as a leading figure in his field.

Ali Ghulam | AI in Healthcare | Best Researcher Award

Posted on by sciencefather

Dr. Ali Ghulam | AI in Healthcare | Best Researcher Award

Assistant Professor at Information Technology Centre, Sindh Agriculture University, Pakistan

Dr. Ghulam Ali is an accomplished academic and researcher specializing in artificial intelligence (AI) and bioinformatics. He earned his Ph.D. in Computer Software and Theory from Shaanxi Normal University, Xi’an, China, in 2020. Currently, he serves as an Assistant Professor at the Information Technology Centre, Sindh Agriculture University, Tandojam. His research focuses on human disease pathway network modeling, biological pathway database discovery, and AI-driven predictions related to proteins, drugs, and diseases. With over 20 published SCI articles in high-impact journals and extensive contributions to machine learning applications in bioinformatics, Dr. Ali is a recognized expert in his field.

Profile

Orcid

Education

Dr. Ali pursued his Ph.D. from Shaanxi Normal University, Xi’an, China, specializing in bioinformatics and AI. His thesis, titled “Prediction of Pathway Related Protein, Drug and Disease Association Based on Complex Network and Deep Learning,” was supervised by Prof. Xiujuan Lei. He completed his M.Phil. in Computer Science with a specialization in Search Engine Optimization from the University of Sindh, Jamshoro. His academic journey began with a Bachelor of Computer Science (BCS-Hons) from the same university. Additionally, he obtained various certifications and diplomas in information technology, further strengthening his expertise in computing and AI.

Experience

Dr. Ali has a strong academic and research background, currently holding the position of Assistant Professor at Sindh Agriculture University, Tandojam. His professional journey includes extensive work on bioinformatics, AI-based predictive models, and computational biology. He has contributed significantly to research in AI applications for human protein sequence analysis, disease detection, and biomedical data transformation. With a deep understanding of AI, deep learning, and machine learning techniques, he has played a pivotal role in advancing bioinformatics research and education.

Research Interests

Dr. Ali’s research primarily revolves around bioinformatics and artificial intelligence. He is particularly focused on human disease pathway modeling, drug-protein interaction prediction, and machine learning applications in genomics. His work involves utilizing AI to enhance precision diagnostics, early-stage disease detection, and advanced biomedical data analysis. By leveraging deep learning and AI-driven methodologies, Dr. Ali aims to improve healthcare analytics and disease treatment strategies. His research has practical implications in the fields of computational biology, digital health frameworks, and AI-driven medical solutions.

Awards and Recognitions

Dr. Ali has received numerous accolades for his contributions to AI and bioinformatics research. His high-impact factor publications and citations reflect his significant contributions to the scientific community. With an H-index of 12 on Google Scholar, an i10-index of 18, and a ResearchGate H-index of 11, his research has been widely recognized and cited. He has also been nominated for various research excellence awards, highlighting his influence in the field of computational biology and AI-driven biomedical advancements.

Publications

Ali, Ghulam, et al. (2025). “StackAHTPs: An explainable antihypertensive peptides identifier based on heterogeneous features and stacked learning approach.” IET Systems Biology, 19(1), e70002. (SCI, IF: 1.9, Cited by: X).

Arif, Muhammad, et al. (2024). “StackDPPred: Multiclass prediction of defensin peptides using stacked ensemble learning with optimized features.” Methods, 230, 129-139. (SCI, IF: 4.02, Cited by: X).

Arif, Muhammad, et al. (2024). “DPI_CDF: Druggable protein identifier using cascade deep forest.” BMC Bioinformatics, 25(1), 1-18. (SCI, IF: 3.09, Cited by: X).

Talpur, Fauzia, et al. (2024). “ML-Based Detection of DDoS Attacks Using Evolutionary Algorithms Optimization.” Sensors, 24(5), 1672. (SCI, IF: 3.09, Cited by: X).

Ghulam, Ali, et al. (2024). “Assessment of Performance of Machine Learning Classification Techniques for Monkey Pox Disease Detection.” Journal of Innovative Intelligent Computing and Emerging Technologies, 1(1), 1-7. (Cited by: X).

Memon, Mukhtiar, et al. (2023). “AiDHealth: An AI-enabled Digital Health Framework for Connected Health and Personal Health Monitoring.” (Cited by: X).

Sikander, Rahu, et al. (2023). “Identification of cancerlectin proteins using hyperparameter optimization in deep learning and DDE profiles.” Mehran University Research Journal of Engineering & Technology, 42(4), 28-40. (WoS, Cited by: X).

Conclusion

Dr. Ghulam Ali is a distinguished researcher and academician in the field of artificial intelligence and bioinformatics. His contributions to AI-driven biomedical research, particularly in disease pathway modeling and predictive analytics, have significantly advanced the field. With a strong publication record, multiple citations, and a commitment to innovation, he continues to influence computational biology and digital health research. His work bridges the gap between AI and medical sciences, paving the way for future breakthroughs in bioinformatics and AI-driven healthcare solutions.